Literature DB >> 10649981

Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity.

J E Saavedra1, P J Shami, L Y Wang, K M Davies, M N Booth, M L Citro, L K Keefer.   

Abstract

We have designed a novel prodrug class that is stable in neutral aqueous media but releases bioactive nitric oxide (NO) on metabolism by esterase. Diazeniumdiolates of structure R(2)N-N(O)=N-OR', in which R' = Na, were reacted with BrCH(2)OAc to convert the spontaneously NO-releasing salts 1a (R(2)N = diethylamino) and 1b (R(2)N = pyrrolidino) to prodrugs 2a (AcOM-DEA/NO) and 2b (AcOM-PYRRO/NO), respectively, where R' = CH(2)OAc. In contrast to anions 1a and 1b (half-lives in pH 7.4 phosphate at 37 degrees C of 2 min and 3 s, respectively), 2a and 2b showed only minimal decomposition after 16 h under these conditions. Very rapid hydrolysis occurred in the presence of porcine liver esterase, however, with free anion 1a being observed as an intermediate in the esterase-induced generation of NO from 2a. The potential utility of this prodrug class is illustrated with a comparison of 1 and 2 as antiproliferative agents in NO-sensitive human leukemia cell lines HL-60 and U937. While the 72-h IC(50)'s for 1a and 1b (which generate NO throughout the medium) in HL-60 cell cultures were >600 microM, those of 2a and 2b were 8.3 and 6.4 microM, respectively. This result is consistent with our hypothesis that 2 is selectively hydrolyzed to 1 and thence to NO intracellularly. For U937 cells, the 72-h IC(50) for both 2a and 2b was 53 microM. By contrast, relatively high antiproliferative IC(50)'s (>100 microM in U937 cells) were observed for analogues in which R' = CH(2)CH(2)SC(O)Me, from which acetyl and 2-mercaptoethyl groups must be successively cleaved to free the NO-releasing diazeniumdiolate function. Within 24 h at initial concentrations of 50 microM, 2a and 2b induced apoptosis in 50% and 57% of the HL-60 cells, respectively (35% and 40% of the U937 cells, respectively). The data reveal significant in vitro antileukemic activity on the part of these novel compounds. Moreover, their substantial ease-of-handling advantages over the anionic diazeniumdiolates from which they are derived suggest their use as convenient agents for probing the biological roles of NO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649981     DOI: 10.1021/jm9903850

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

1.  Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO.

Authors:  Steven Hutchens; Yefim Manevich; Lin He; Kenneth D Tew; Danyelle M Townsend
Journal:  Invest New Drugs       Date:  2010-03-16       Impact factor: 3.850

Review 2.  Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets.

Authors:  Danyelle M Townsend; Victoria L Findlay; Kenneth D Tew
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

4.  Guest-release control in enzyme-sensitive, amphiphilic-dendrimer-based nanoparticles through photochemical crosslinking.

Authors:  Krishna R Raghupathi; Malar A Azagarsamy; S Thayumanavan
Journal:  Chemistry       Date:  2011-09-02       Impact factor: 5.236

5.  Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.

Authors:  Gail M Johnson; Tyler J Chozinski; Elyssia S Gallagher; Craig A Aspinwall; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

6.  Effects of zinc-fortified drinking skim milk (as functional food) on cytokine release and thymic hormone activity in very old persons: a pilot study.

Authors:  Laura Costarelli; Robertina Giacconi; Marco Malavolta; Andrea Basso; Francesco Piacenza; MariLuisa DeMartiis; Elvio Giannandrea; Carlo Renieri; Franco Busco; Roberta Galeazzi; Eugenio Mocchegiani
Journal:  Age (Dordr)       Date:  2014-04-26

7.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

8.  Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response.

Authors:  Danyelle M Townsend; Yefim Manevich; Lin He; Ying Xiong; Robert R Bowers; Steven Hutchens; Kenneth D Tew
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

9.  Glycosylated PROLI/NO derivatives as nitric oxide prodrugs.

Authors:  Rahul S Nandurdikar; Anna E Maciag; Sam Y Hong; Harinath Chakrapani; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2010-01-01       Impact factor: 6.005

10.  Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cells.

Authors:  Monika Z Kaczmarek; Ryan J Holland; Stephen A Lavanier; Jami A Troxler; Valentyna I Fesenkova; Charlotte A Hanson; Joan L Cmarik; Joseph E Saavedra; Larry K Keefer; Sandra K Ruscetti
Journal:  Leuk Res       Date:  2013-12-12       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.